The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains (Q28210453)

0 references

M Warmuth

0 references

I Kleinlein

0 references

S Reis

0 references

M Hallek

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

0 references

language of work or name

English

0 references

publication date

February 2003

0 references

0 references

0 references

0 references

283-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

The Src Family Kinase Hck Interacts with Bcr-Abl by a Kinase-independent Mechanism and Phosphorylates the Grb2-binding Site of Bcr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Src family tyrosine kinases and growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Cloning, sequence determination and functional expression of the genes encoding adenovirus type-4 polymerase and the terminal protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Insights into Src kinase functions: structural comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402778